Production (Stage)
Ikena Oncology, Inc.
IKNA
$1.43
$0.064.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 659.00K | 1.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 659.00K | 1.84M |
| Cost of Revenue | 15.16M | 15.51M | 21.44M | 31.14M | 38.97M |
| Gross Profit | -15.16M | -15.51M | -21.44M | -30.48M | -37.13M |
| SG&A Expenses | 22.43M | 23.32M | 23.68M | 24.38M | 25.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.57M | 48.27M | 54.55M | 64.95M | 74.04M |
| Operating Income | -41.57M | -48.27M | -54.55M | -64.29M | -72.20M |
| Income Before Tax | -30.64M | -41.55M | -49.08M | -59.66M | -66.78M |
| Income Tax Expenses | 106.00K | 153.00K | 152.00K | -63.00K | -73.00K |
| Earnings from Continuing Operations | -30.74 | -41.71 | -49.23 | -59.60 | -66.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.74M | -41.71M | -49.23M | -59.60M | -66.71M |
| EBIT | -41.57M | -48.27M | -54.55M | -64.29M | -72.20M |
| EBITDA | -41.22M | -47.91M | -54.06M | -63.58M | -71.34M |
| EPS Basic | -0.64 | -0.86 | -1.02 | -1.24 | -1.43 |
| Normalized Basic EPS | -0.36 | -0.50 | -0.58 | -0.72 | -0.85 |
| EPS Diluted | -0.64 | -0.86 | -1.02 | -1.24 | -1.43 |
| Normalized Diluted EPS | -0.36 | -0.50 | -0.58 | -0.72 | -0.85 |
| Average Basic Shares Outstanding | 193.03M | 193.03M | 193.03M | 192.65M | 187.83M |
| Average Diluted Shares Outstanding | 193.03M | 193.03M | 193.03M | 192.65M | 187.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |